LDX lumos diagnostics holdings limited

A lot of pathology tests never get, or even have an application...

  1. 11,596 Posts.
    lightbulb Created with Sketch. 808
    A lot of pathology tests never get, or even have an application for, a CLIA waiver, as obviously it is not applicable.

    PIQ had their PromarkerD CPT/PLA code approved in Jan 2023, had a licensing deal in May 2023, and got assigned a CMS price in Sept 2023, which become effective Jan 2024.

    The BARDA deal seems like a flag to get the CMS coverage application supported. Would be good to have CMS pricing assigned by Feb next year. (They had the PLA code assigned in Dec 2023).
    Last edited by CaptainBarnacles: 12/10/24
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
2.7¢
Change
0.000(0.00%)
Mkt cap ! $20.21M
Open High Low Value Volume
0.0¢ 0.0¢ 0.0¢ $0 0

Buyers (Bids)

No. Vol. Price($)
3 318288 2.7¢
 

Sellers (Offers)

Price($) Vol. No.
2.8¢ 45000 2
View Market Depth
Last trade - 10.04am 18/06/2025 (20 minute delay) ?
LDX (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.